Publication: Evaluation of indoleamine 2, 3 dioxygenase (IDO) gene polymorphisms in COVID-19
dc.contributor.author | Karaca, Mert | |
dc.contributor.author | Arslan, Gözde | |
dc.contributor.author | Ermiş, Diğdem Yöyen | |
dc.contributor.author | Bal, Salih Haldun | |
dc.contributor.author | Uzaslan, Esra Kunt | |
dc.contributor.author | Özkalemkaş, Fahir | |
dc.contributor.author | Macunluoğlu, Aslı Ceren | |
dc.contributor.author | Budak, Ferah | |
dc.contributor.author | Akalın, Halis | |
dc.contributor.author | Oral, Haluk Barbaros | |
dc.contributor.buuauthor | KARACA, MERT | |
dc.contributor.buuauthor | Arslan, Gözde | |
dc.contributor.buuauthor | YÖYEN ERMİŞ, DİĞDEM | |
dc.contributor.buuauthor | BAL, SALİH HALDUN | |
dc.contributor.buuauthor | Uzaslan, Esra Kunt | |
dc.contributor.buuauthor | ÖZKALEMKAŞ, FAHİR | |
dc.contributor.buuauthor | Macunluoğlu, Aslı Ceren | |
dc.contributor.buuauthor | BUDAK, FERAH | |
dc.contributor.buuauthor | AKALIN, EMİN HALİS | |
dc.contributor.buuauthor | ORAL, HALUK BARBAROS | |
dc.contributor.department | Tıp Fakültesi | |
dc.contributor.department | Göğüs Hastalıkları Ana Bilim Dalı | |
dc.contributor.orcid | 0000-0002-6802-5998 | |
dc.contributor.orcid | 0000-0001-7625-9148 | |
dc.contributor.orcid | 0000-0001-7530-1279 | |
dc.contributor.orcid | 0000-0003-0463-6818 | |
dc.contributor.orcid | 0000-0002-6802-5998 | |
dc.contributor.orcid | 0000-0001-6711-676X | |
dc.contributor.researcherid | IZP-9398-2023 | |
dc.contributor.researcherid | AAU-8952-2020 | |
dc.contributor.researcherid | K-7285-2012 | |
dc.contributor.researcherid | F-4657-2014 | |
dc.contributor.researcherid | JFS-2013-2023 | |
dc.contributor.researcherid | AAG-7406-2021 | |
dc.contributor.researcherid | GYL-2038-2022 | |
dc.contributor.researcherid | KBR-5535-2024 | |
dc.contributor.researcherid | AAI-1004-2021 | |
dc.contributor.researcherid | JLE-5241-2023 | |
dc.contributor.researcherid | GBP-6589-2022 | |
dc.date.accessioned | 2024-06-28T06:42:39Z | |
dc.date.available | 2024-06-28T06:42:39Z | |
dc.date.issued | 2021-08-01 | |
dc.identifier.eissn | 1521-4141 | |
dc.identifier.endpage | 230 | |
dc.identifier.issn | 0014-2980 | |
dc.identifier.startpage | 230 | |
dc.identifier.uri | https://hdl.handle.net/11452/42555 | |
dc.identifier.volume | 51 | |
dc.identifier.wos | 000753366401190 | |
dc.indexed.wos | WOS.SCI | |
dc.language.iso | en | |
dc.publisher | Wiley | |
dc.relation.journal | European Journal of Immunology | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.subject | Immune regulation and therapy | |
dc.subject | Inflammatory disease | |
dc.subject | Molecular immunology | |
dc.subject | Viral infections | |
dc.subject | Immunology | |
dc.title | Evaluation of indoleamine 2, 3 dioxygenase (IDO) gene polymorphisms in COVID-19 | |
dc.type | Meeting Abstract | |
dspace.entity.type | Publication | |
local.contributor.department | Tıp Fakültesi/İmmunoloji Ana Bilim Dalı | |
local.contributor.department | Tıp Fakültesi/Göğüs Hastalıkları Ana Bilim Dalı | |
local.contributor.department | Tıp Fakültesi/İç Hastalıkları Ana Bilim Dalı | |
local.contributor.department | Tıp Fakültesi/Biostatik Ana Bilim Dalı | |
local.contributor.department | Tıp Fakültesi/Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Ana Bilim Dalı | |
relation.isAuthorOfPublication | 52dddfd9-75c4-47a7-af7f-838817a9043e | |
relation.isAuthorOfPublication | 2af06def-4b00-4fe9-a19d-defb59369991 | |
relation.isAuthorOfPublication | a539e15c-3358-43ad-a410-a601c8d8760d | |
relation.isAuthorOfPublication | 6d4676a2-f825-4560-bfa8-c7eb6daf748d | |
relation.isAuthorOfPublication | 26fb3aa9-55a8-4fa3-8a4a-9c449958d4f5 | |
relation.isAuthorOfPublication | 4fb46529-3295-4383-97b1-7c494ff32c24 | |
relation.isAuthorOfPublication | bc853dab-a811-42b9-b03b-6d5fe067efe8 | |
relation.isAuthorOfPublication.latestForDiscovery | 52dddfd9-75c4-47a7-af7f-838817a9043e |